AffiliationDepartment of Medical Oncology, Christie Hospital NHS Trust and Holt Radium Institute, Wilmslow Road, Manchester M20 4BX, United Kingdom.
MetadataShow full item record
AbstractCancer management in the older patient is a growing concern, particularly with the increasing geriatric population and the high incidence of cancer among these individuals. Incidence of lung cancer in particular is known to rise with age. This article reviews prognosis, treatment options, and decision-making issues for both clinician and patient with respect to both non-small-cell and small-cell lung cancer in this population. Research findings dealing with response rates, survival rates, and symptom control in this age group are reviewed for radiotherapy, surgery, and for various chemotherapy agents, including gemcitabine, the taxanes, vinorelbine, and the topoisomerase 1 inhibitors. Quality- of-life issues are also addressed.
CitationManagement of elderly patients with lung cancer. 2000, 2 (1):90-5 Curr Oncol Rep
JournalCurrent Oncology Reports
- The role of new agents in advanced non-small-cell lung carcinoma.
- Authors: Langer CJ
- Issue date: 2000 Jan
- Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review.
- Authors: Clegg A, Scott DA, Hewitson P, Sidhu M, Waugh N
- Issue date: 2002 Jan
- [New cytostatics in the therapy of non-small cell bronchial carcinoma].
- Authors: Serke M, Schönfeld N, Loddenkemper R
- Issue date: 1998 Jun
- Vinorelbine: a review of its use in elderly patients with advanced non-small cell lung cancer.
- Authors: Curran MP, Plosker GL
- Issue date: 2002
- Gemcitabine concurrent with thoracic radiotherapy after induction chemotherapy with gemcitabine/vinorelbine in locally advanced non-small cell lung cancer: a phase I study.
- Authors: Gagel B, Piroth M, Pinkawa M, Reinartz P, Zimny M, Fischedik K, Stanzel S, Breuer C, Skobel E, Asadpour B, Schmachtenberg A, Buell U, Eble MJ
- Issue date: 2006 May